mifepristone has been researched along with Keratoacanthoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alexander, CL; Chan, WC; Greenhalgh, DA; Quinn, JA; Wu, H; Yao, D | 1 |
1 other study(ies) available for mifepristone and Keratoacanthoma
Article | Year |
---|---|
Fos cooperation with PTEN loss elicits keratoacanthoma not carcinoma, owing to p53/p21 WAF-induced differentiation triggered by GSK3beta inactivation and reduced AKT activity.
Topics: Animals; Cyclin D; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Disease Progression; Keratinocytes; Keratoacanthoma; Mice; Mifepristone; Oncogene Protein v-akt; Oncogene Proteins v-fos; PTEN Phosphohydrolase; Repressor Proteins; Skin Neoplasms; Tumor Suppressor Protein p53 | 2008 |